Avanos Medical Inc (NYSE: AVNS) is -0.69% lower on its value in year-to-date trading and has touched a low of $14.98 and a high of $25.36 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AVNS stock was last observed hovering at around $15.80 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $15.81, the stock is 0.15% and -8.92% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.3 million and changing 0.06% at the moment leaves the stock -22.41% off its SMA200. AVNS registered -18.80% loss for a year compared to 6-month loss of -30.04%. The firm has a 50-day simple moving average (SMA 50) of $17.3578 and a 200-day simple moving average (SMA200) of $20.3756.
The stock witnessed a -1.68% gain in the last 1 month and extending the period to 3 months gives it a -29.73%, and is -1.50% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.51% over the week and 3.00% over the month.
Avanos Medical Inc (AVNS) has around 3771 employees, a market worth around $726.58M and $681.50M in sales. Current P/E ratio is 46.87 and Fwd P/E is 9.30. Profit margin for the company is 2.30%. Distance from 52-week low is 5.54% and -37.66% from its 52-week high. The company has generated returns on investments over the last 12 months (1.11%).
with sales reaching $177.23M over the same period.The EPS is expected to grow by 28.64% this year, but quarterly earnings will post 1.80% year-over-year. Quarterly sales are estimated to grow 2.27% in year-over-year returns.
Avanos Medical Inc (AVNS) Top Institutional Holders
361.0 institutions hold shares in Avanos Medical Inc (AVNS), with institutional investors hold 99.38% of the company’s shares. The shares outstanding are 45.95M, and float is at 44.82M with Short Float at 1.52%. Institutions hold 96.49% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 7.01 million shares valued at $139.66 million. The investor’s holdings represent 15.1758% of the AVNS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.27 million shares valued at $104.98 million to account for 11.4072 of the shares outstanding. The other top investors are RGM CAPITAL, LLC which holds 3.17 million shares representing 6.8646% and valued at over $63.18 million, while DIMENSIONAL FUND ADVISORS LP holds 5.5793 of the shares totaling 2.58 million with a market value of $51.35 million.
Avanos Medical Inc (AVNS) Insider Activity
The most recent transaction is an insider sale by Greiner Michael, the company’s SVP – Chief Financial Officer. SEC filings show that Greiner Michael sold 8,000 shares of the company’s common stock on Mar 14 ’24 at a price of $19.12 per share for a total of $0.15 million. Following the sale, the insider now owns 0.15 million shares.
Avanos Medical Inc disclosed in a document filed with the SEC on Mar 11 ’24 that Shimer Julie Ann (Director) bought a total of 500 shares of the company’s common stock. The trade occurred on Mar 11 ’24 and was made at $19.85 per share for $9925.0. Following the transaction, the insider now directly holds 50090.0 shares of the AVNS stock.
